查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589156

冠状动脉绕道手术移植物市场：按方法、技术和产品划分 - 2025-2030 年全球预测

Coronary Artery Bypass Grafts Market by Method (Minimally Invasive Direct CABG, Off-Pump, On-Pump), Procedure (Double CABG Surgery, Quadruple CABG Surgery, Single CABG Surgery), Product - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年冠状动脉绕道手术移植物市场价值为171.1亿美元，预计到2024年将达到181.6亿美元，复合年增长率为6.19%，到2030年将达到260.5亿美元。

冠状动脉绕道手术手术（CABG）市场涉及透过将血液引导至阻塞或患病动脉来改善心臟血流量的外科手术。对 CABG 的需求源自于其在治疗冠状动脉疾病 (CAD) 中的重要作用，而冠状动脉疾病是全球死亡的主要原因。 CABG 主要用于医院和心臟中心，在这些中心进行复杂的手术以改善患者的预后。最终用途范围广泛，可解决急诊和择期手术中的急性冠状动脉症状。 CABG 市场的关键成长要素包括由于人口老化和生活方式相关风​​险因素导致 CAD 盛行率增加、手术技术的进步以及合成和组织工程选择等移植材料的创新。对微创手术不断增长的需求代表着一个潜在的机会，因为它可以缩短康復时间并改善患者体验。策略建议包括投资研发以开发新型植入材料和技术、扩展到新兴市场以及与医疗保健提供者建立伙伴关係以更好地推广。然而，该市场面临可能影响其成长轨蹟的限制，包括高昂的手术成本、监管挑战以及血管成形术和置入术等替代疗法的可用性。为了应对这些挑战，需要专注于降低成本策略并改善病患教育，以强调 CABG 的益处。需要创新的领域包括开发更耐用和生物相容的移植材料以及机器人辅助手术的进步。此外，可以利用巨量资料和人工智慧透过客製化治疗和预测併发症来改善患者的治疗结果。市场仍然充满竞争，无论是老牌企业还是专注于技术突破的新进者。为了取得成功，公司必须专注于技术进步、成本效率和策略联盟，以应对不断变化的情况。

主要市场统计
基准年[2023] 171.1亿美元
预测年份 [2024] 181.6亿美元
预测年份 [2030] 260.5亿美元
复合年增长率（%） 6.19%

市场动态：快速发展的冠状动脉绕道手术移植市场的关键市场洞察

供应和需求的动态相互作用正在改变冠状动脉绕道手术手术市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 冠状动脉疾病盛行率增加
    • 医疗保健支出不断增加，心臟专科医疗中心数量不断增加
    • CABG手术优惠报销政策
  • 市场限制因素
    • 对冠状动脉绕道手术併发症和风险的担忧
  • 市场机会
    • 机器人辅助手术等微创CABG技术的发展
    • 手术技术和影像技术的进步
  • 市场挑战
    • 预防冠状动脉疾病的替代技术的可用性

波特五力：驾驭冠状动脉绕道手术移植物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解冠状动脉绕道手术移植市场的外部影响

外部宏观环境因素在塑造冠状动脉绕道手术移植物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解冠状动脉绕道手术手术市场的竞争格局

冠状动脉绕道手术物市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵冠状动脉绕道手术旁路移植物市场供应商的绩效评估

FPNV 定位矩阵是评估冠状动脉绕道手术移植物市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了冠状动脉绕道手术移植市场的成功之路

冠状动脉绕道手术移植物市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 冠状动脉疾病盛行率增加
      • 医疗保健成本不断上升，心臟专科中心数量不断增加
      • CABG手术优惠报销政策
    • 抑制因素
      • 对 CABG 手术相关併发症和风险的担忧
    • 机会
      • 机器人辅助手术等微创CABG技术的发展
      • 手术和影像技术的进步
    • 任务
      • 预防冠状动脉疾病的替代技术的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章冠状动脉绕道手术移植市场：依方法分类

  • 微创直接冠状动脉绕道术
  • 关闭泵浦
  • 在帮浦上

第七章冠状动脉绕道手术绕道移植物市场分步实施

  • 双冠状动脉绕道手术
  • 4 次冠状动脉绕道手术
  • 单次冠状动脉绕道手术
  • 三重冠状动脉绕道手术

第八章冠状动脉绕道手术移植物市场：副产品

  • 胃网膜动脉
  • 乳内动脉移植物
  • 桡动脉
  • 大隐静脉移植物

第九章美洲冠状动脉绕道手术移植物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太冠状动脉绕道手术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的冠状动脉绕道手术手术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • enVVeno Medical Corporation
  • Genesee Biomedical Inc.
  • Getinge AB
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • Peters Surgical
  • Scanlan International, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Transonic Systems Inc.
  • Vascular Graft Solutions Ltd.
Product Code: MRR-2A0283E2559F

The Coronary Artery Bypass Grafts Market was valued at USD 17.11 billion in 2023, expected to reach USD 18.16 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 26.05 billion by 2030.

The coronary artery bypass grafts (CABG) market involves surgical procedures used to improve blood flow to the heart by redirecting blood around clogged or diseased arteries. The necessity of CABG arises from its critical role in treating coronary artery disease (CAD), a leading cause of mortality globally. Its application is primarily in hospitals and cardiac centers, where complex procedures are performed to improve patient outcomes. End-use scope is broad, addressing acute coronary symptoms in both emergency situations and elective surgeries. Key growth factors in the CABG market include the increasing prevalence of CAD due to aging populations and lifestyle-related risk factors, advancements in surgical techniques, and innovations in graft materials like synthetic and tissue-engineered options. The growing demand for minimally invasive procedures represents a potential opportunity, as it can reduce recovery times and improve patient experiences. Strategic recommendations include investing in R&D for developing novel graft materials and techniques, expanding into emerging markets, and forming partnerships with healthcare providers for better outreach. However, the market faces limitations such as the high cost of procedures, regulatory challenges, and the availability of alternative treatments like angioplasty and stenting that might affect the growth trajectory. Addressing these challenges requires a focus on cost-reduction strategies and improved patient education to highlight the benefits of CABG. Areas ripe for innovation include the development of more durable and biocompatible graft materials, as well as advancements in robotic-assisted surgeries. Additionally, big data and AI can be leveraged to enhance patient outcomes by tailoring treatments and predicting complications. The market remains competitive, characterized by both established players and new entrants focusing on technological breakthroughs. To succeed, businesses must maintain a keen focus on technological advancements, cost-efficiency, and strategic collaborations to navigate the evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 17.11 billion
Estimated Year [2024] USD 18.16 billion
Forecast Year [2030] USD 26.05 billion
CAGR (%) 6.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Artery Bypass Grafts Market

The Coronary Artery Bypass Grafts Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of coronary artery diseases
    • Rising healthcare expenditure and growing number of cardiac specialty centers
    • Favorable reimbursement policies for CABG surgery
  • Market Restraints
    • Concerns associated with complications and risk of CABG surgery
  • Market Opportunities
    • Development of minimally invasive CABG techniques such as robotic-assisted surgery
    • Advancements in surgical techniques and imaging technologies
  • Market Challenges
    • Availability of alternate technologies for prevention of coronary artery diseases

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Artery Bypass Grafts Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Artery Bypass Grafts Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Artery Bypass Grafts Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Artery Bypass Grafts Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Artery Bypass Grafts Market

A detailed market share analysis in the Coronary Artery Bypass Grafts Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Artery Bypass Grafts Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Artery Bypass Grafts Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Artery Bypass Grafts Market

A strategic analysis of the Coronary Artery Bypass Grafts Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Bypass Grafts Market, highlighting leading vendors and their innovative profiles. These include AtriCure, Inc., Boston Scientific Corporation, Edwards Lifesciences, enVVeno Medical Corporation, Genesee Biomedical Inc., Getinge AB, KARL STORZ SE & Co. KG, Medtronic PLC, Peters Surgical, Scanlan International, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Transonic Systems Inc., and Vascular Graft Solutions Ltd..

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Bypass Grafts Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Minimally Invasive Direct CABG, Off-Pump, and On-Pump.
  • Based on Procedure, market is studied across Double CABG Surgery, Quadruple CABG Surgery, Single CABG Surgery, and Triple CABG Surgery.
  • Based on Product, market is studied across Gastroepiploic Artery, Internal Thoracic Artery Grafts, Radial Artery, and Saphenous Vein Grafts.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of coronary artery diseases
      • 5.1.1.2. Rising healthcare expenditure and growing number of cardiac specialty centers
      • 5.1.1.3. Favorable reimbursement policies for CABG surgery
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with complications and risk of CABG surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of minimally invasive CABG techniques such as robotic-assisted surgery
      • 5.1.3.2. Advancements in surgical techniques and imaging technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternate technologies for prevention of coronary artery diseases
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Coronary Artery Bypass Grafts Market, by Method

  • 6.1. Introduction
  • 6.2. Minimally Invasive Direct CABG
  • 6.3. Off-Pump
  • 6.4. On-Pump

7. Coronary Artery Bypass Grafts Market, by Procedure

  • 7.1. Introduction
  • 7.2. Double CABG Surgery
  • 7.3. Quadruple CABG Surgery
  • 7.4. Single CABG Surgery
  • 7.5. Triple CABG Surgery

8. Coronary Artery Bypass Grafts Market, by Product

  • 8.1. Introduction
  • 8.2. Gastroepiploic Artery
  • 8.3. Internal Thoracic Artery Grafts
  • 8.4. Radial Artery
  • 8.5. Saphenous Vein Grafts

9. Americas Coronary Artery Bypass Grafts Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Coronary Artery Bypass Grafts Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Coronary Artery Bypass Grafts Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AtriCure, Inc.
  • 2. Boston Scientific Corporation
  • 3. Edwards Lifesciences
  • 4. enVVeno Medical Corporation
  • 5. Genesee Biomedical Inc.
  • 6. Getinge AB
  • 7. KARL STORZ SE & Co. KG
  • 8. Medtronic PLC
  • 9. Peters Surgical
  • 10. Scanlan International, Inc.
  • 11. Stryker Corporation
  • 12. Teleflex Incorporated
  • 13. Terumo Corporation
  • 14. Transonic Systems Inc.
  • 15. Vascular Graft Solutions Ltd.

LIST OF FIGURES

  • FIGURE 1. CORONARY ARTERY BYPASS GRAFTS MARKET RESEARCH PROCESS
  • FIGURE 2. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY BYPASS GRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CORONARY ARTERY BYPASS GRAFTS MARKET DYNAMICS
  • TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE DIRECT CABG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY DOUBLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY QUADRUPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY TRIPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GASTROEPIPLOIC ARTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY INTERNAL THORACIC ARTERY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SAPHENOUS VEIN GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2023